Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Leo Pharma AS

www.leo-pharma.com

Latest From Leo Pharma AS

Leo Sets Up For A David & Goliath Showdown In Atopic Dermatitis

Scrip talked to Leo Pharma's new CEO Catherine Mazzacco about going up against big biopharma players in dermatology and plans to file tralokinumab in 2020.

Dermatology Business Strategies

Atopic Dermatitis: Ruxolitinib And Baricitinib Spearheading New Therapies

Top-line Phase III results from Incyte’s TruE-AD2 study of ruxolitinib cream and Eli Lilly’s BREEZE-AD4 and BREEZE-AD5 studies of oral baricitinib show that the compounds achieved primary endpoints in atopic dermatitis, and they may eventually challenge Sanofi’s Dupixent’s growth in the sector.


 

Dermatology Clinical Trials

JT Gains World-First Topical JAK Inhibitor Approval

Latest new drug approvals in Japan include the first anywhere for a topical JAK inhibitor and also a marketing clearance for a new contender in the large prostate cancer space.
Japan Approvals

Sweden's Karo Snaps Up LEO's OTC Derma Brands

Karo Pharma will pay LEO Pharma €90m for a basket of dermatology and anti-hemorrhoid brands to expand its European footprint.
Deals OTC Drugs
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Blood & Coagulation Disorders & Products
  • Cardiovascular
  • Dermatology
  • Infectious & Viral Diseases
  • Musculoskeletal & Connective Tissue Disorders
  • Renal System
  • Respiratory, Pulmonary
  • Alias(es)
  • Leo Pharmaceutical Products Ltd.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Denmark
  • Parent & Subsidiaries
  • Leo Pharma AS
  • Senior Management
  • Catherine Mazzacco, Pres. & CEO
    Anders Kronborg, EVP, Global Fin. & Bus. Services
    Kim Kjoller, EVP, Global R&D
  • Contact Info
  • Leo Pharma AS
    Phone: (45) 4494 5888
    55 Industriparken
    Ballerup, DK-2750
    Denmark
UsernamePublicRestriction

Register